Wenwang Lang, Bei Huang, Gaofeng Zhang, Lian Deng, Huirong Lu, Meijun Lu, Yufei Pan. "Cost-effectiveness of cabozantinib versus placebo for advanced neuroendocrine tumors from crossover-adjusted analysis in the United States and China." Scientific Reports, 2026. doi:10.1038/s41598-026-39026-0